Abstract submission for the conference has closed.
Abstracts submitted will be reviewed by the Program Chairs for potential poster presentation. If selected, the presenting author will be required to accept the invitation to present, register for the conference, and provide current financial disclosure information.
Abstract notifications will be sent to corresponding authors in mid-August.
A limited number of travel awards in the amount of $1,000 (per award) will be available from AASLD for trainees in the field of hepatology with a special interest in the conference topic. In order to qualify for a travel award, an abstract on related research must be submitted and accepted. Accepted abstracts will be presented as poster presentations. The Program Chairs will determine the award recipients and the presentation type. Corresponding authors will be notified regarding the trainee travel award in mid-August 2017.
The initial responsibility for adherence to ethical guidelines lies with the responsible investigators submitting their research findings to AASLD meetings or journals. First, for reports of research using human subjects, provide assurance that (a) informed consent in writing was obtained from each patient and (b) the study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the appropriate institutional review committee. Refer to individual patients by number, not by initials.
Second, in studies involving animal experimentation, provide assurance that all animals received humane care according to the criteria outlined in the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 86-23 revised 1985).
The corresponding author also certifies that all authors named in this abstract have agreed to its submission for presentation at The Emerging Trends Conference.
AASLD is an accredited provider of continuing medical education and adheres to the policies and standards set forth by the Accreditation Council for Continuing Medical Education (ACCME). As such, all faculty members (including Program Chairs, panelists, moderators and speakers) and abstract authors are required to disclose relationships with commercial interests. A commercial interest is defined as "any entity developing, producing, marketing, re-selling or distributing healthcare goods or services consumed by or used on patients."
To ensure compliance, AASLD expects that all program content and related materials will promote improvements or quality in health care and not a specific proprietary business interest or commercial bias.
AASLD staff and program committees reserve the right to change an abstract if the use of a trade name may be mistaken for commercial propaganda and may replace proprietary names with generic names. Logos promoting a commercial interest will be removed from any and all slides before presentation.